Workforce Solutions names DHR the 2017 Employer of the Year

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

Edinburg, TX – 10/31/17 – DHR Health is proud to announce it has been recognized as the 2017 Employer of the Year by Workforce Solutions. This honor is awarded to an employer whose efforts and initiatives have had an extraordinary effect on the state of Texas, other employers, workers, and the communities in which the employer does business.

DHR Health has over 4,700 employees, including over 1,300 nurses! As one of the largest employers in Hidalgo County, DHR Health continues to work toward the development of new career opportunities for members of the community and the advancement of education for current employees. In 2017, DHR Health and Workforce Solutions secured funding for workforce training through the Texas Workforce Commission (TWC) Skills Development Fund. This $2.6 million grant will provide 2,961 new and existing workers in the healthcare field with advanced medical training.

DHR Health was also instrumental in the creation of a dual enrollment nursing education program for high school students – a first of its kind program that provides students with a pathway into health professions. The dual enrollment program was formed in collaboration with Pharr-San Juan-Alamo Independent School District (PSJA ISD), South Texas College, Region One Education Service Center (Region One), and Schools for South Texas Independent School District (South Texas ISD). The dual enrollment program allows for expanded educational opportunities while also addressing the healthcare needs of our region by working to alleviate the nursing shortage that challenges local healthcare providers.  The program provides high school students the opportunity to receive their Associate Degree in Nursing while still in high school; the first cohort received their diplomas in May 2017.

- Advertisement -

DHR Health will be presented with the Texas Workforce Solutions 2017 Employer of the Year award at the 2017 RGV LEAD Conference: Education and Workforce Summit on November 16-17, 2017. For more information about the RGV LEAD Conference or the Employer of the Year award, please call (956) 928-5000.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -